Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial
Clinical trial NCT04727307 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04727307
- Sponsor
- University Hospital, Montpellier
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2028-02-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.